Though in the midst of a 4 day uptrend, gaining a total of 11.79%, (34 cents), The prevailing bullish trend is beginning to fade following today's downbeat session. An influx of sellers pushed the leading medical and recreational marijuana dispensary to end the session lower around $2.56, while establishing a $2.51 to $2.65 session range today.
Data from United States concerning Pending Home Sales was released yesterday at 14:00 UTC. Newly published figures emphasized continued decline from last month's figure of 0.8% to -5.2% this month. Highly important GDP data from United States beat analyst expectations of two with a reading of 1.1.
While price action maintains a negative bias, United States Core PCE Price Index (MoM) (Mar) came out at 0.3, while a consensus of analysts was expecting 0.3.
Curaleaf Holdings, Inc.'s upper Bollinger Band® is at $2.68 which indicates a further downward move may follow. In contrast, Curaleaf could begin to recover as it approaches significant support, now 6 cents away from $2.5. Dipping below could be an indication that further losses are ahead.
Several technical indicators are adding weight to the bearish momentum seen today and forecasting Curaleaf to extend its recent losses.
Curaleaf was not the only decliner in the health care sector; Sanofi lost 4.35% today and closed at $53.65.
On the other hand, positive performances could be seen by looking at other health care stocks as Thermo Fisher Scientific was up 2.19%.
Curaleaf hit a significant low of $2.29 around 3 days ago, but has since recovered 14.85%.